A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Bibliografski detalji
Glavni autor: Choki, Kinley
Daljnji autori: Chowdhury, Namara Mariam
Format: Disertacija
Jezik:English
Izdano: Brac University 2024
Teme:
Acute lymphoblastic leukemia
Leukemia
R/R B-cell precursor ALL
FDA
Blood cancer
Lymphoblastic leukemia.
Cancer > Immunotherapy.
Monoclonal antibodies > Therapeutic use.
Online pristup:http://hdl.handle.net/10361/24298

Internet

http://hdl.handle.net/10361/24298

Similar Items